News
![The SARS-CoV-2 coronavirus](https://pharmaphorum.com/wp-content/uploads/2020/03/49534865371_7219ecfbcd_k.jpg)
AbbVie begins trials of COVID-19 antibody therapy
AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the therapy in from Harbour BioMed and Utrecht University.<